Advancing R&D with a scientific mindset and academic/business sense

webinar

Fri, 21 Sep 2018, 16:00 CEST (Berlin)

Dr. Guillermo Morales, PhD, MBA, CEO of Innoventyx

Advancing R&D with a scientific mindset and academic/business sense

How do you start a research program and advance it with the limited funds you have? This is a common problem we all face whether you are in industry or in academia. In drug discovery if you don’t have a way to know what compounds you should buy/make then your chances of success are the same as buying a lottery ticket. And even if you have a promising hit/lead compound, how will you improve it? How much should you improve it? And to what end? A publication, patent filing, grant application? In this webinar Dr. Morales will cover these points, foundations to tackle obstacles and make decisions to start and advance research projects.

Current news

category
Events
BioSolveIT at 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg
December 17, 2025 15:19 CET
BioSolveIT is honored and excited to participate in the 34th GP2A 2026 Conference on Medicinal Chemistry in Gothenburg. From August 26 to 28, 2026, the Group for the Promotion of Pharmaceutical Chemistry in Academia (GP2A), a member-led network of academic medicinal chemists working at universities and research institutes in Europe,...
Read on
BioSolveIT wrapped 2025
December 15, 2025 06:18 CET
Our Year in Drug Discovery In 2025, we focused on bridging the gap between computational prediction and compound tangibility. Along the way we refined and evolved our platforms to ensure that drug discovery is not only faster, but also more accessible and reliable for researchers everywhere. This year saw the...
Read on
category
Challenge
Emina Yekt Yilmaz Wins Scientific Challenge Winter 2024!
December 9, 2025 14:52 CET
It is our greatest pleasure to announce the winner of the Winter 2024 edition of the Scientific Challenge: the winner is Emine Yekta Yilmaz from Haceteppe and Gazi Universities (Ankara, Turkey) with her project ‘Leveraging AI and Physics-Based Screening for the Identification of sEH Inhibitors’. Based on standardized compound datasets...
Read on